Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs SYMBIOX INVESTMENT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS SYMBIOX INVESTMENT NOVARTIS/
SYMBIOX INVESTMENT
 
P/E (TTM) x 81.4 73.4 110.8% View Chart
P/BV x 2.6 0.2 1,517.4% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 NOVARTIS   SYMBIOX INVESTMENT
EQUITY SHARE DATA
    NOVARTIS
Mar-21
SYMBIOX INVESTMENT
Mar-20
NOVARTIS/
SYMBIOX INVESTMENT
5-Yr Chart
Click to enlarge
High Rs7701 79,381.4%   
Low Rs501NA 263,684.2%   
Sales per share (Unadj.) Rs154.50.3 46,559.8%  
Earnings per share (Unadj.) Rs8.50 110,362.0%  
Cash flow per share (Unadj.) Rs13.40 174,572.6%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.29.9 2,929.6%  
Shares outstanding (eoy) m24.6931.29 78.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.11.7 235.3%   
Avg P/E ratio x75.176.4 98.3%  
P/CF ratio (eoy) x47.576.4 62.1%  
Price / Book Value ratio x2.20.1 3,740.3%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,69118 86,463.7%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0851 80,377.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,81410 36,738.9%  
Other income Rs m33210 3,461.9%   
Total revenues Rs m4,14620 20,758.6%   
Gross profit Rs m267-9 -2,878.1%  
Depreciation Rs m1220-   
Interest Rs m770-   
Profit before tax Rs m4000 125,125.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1910 239,250.0%   
Profit after tax Rs m2090 87,083.3%  
Gross profit margin %7.0-89.3 -7.8%  
Effective tax rate %47.824.8 192.9%   
Net profit margin %5.52.3 239.4%  
BALANCE SHEET DATA
Current assets Rs m9,224320 2,882.2%   
Current liabilities Rs m3,5739 42,030.6%   
Net working cap to sales %148.23,001.1 4.9%  
Current ratio x2.637.6 6.9%  
Inventory Days Days1765,958 3.0%  
Debtors Days Days370-  
Net fixed assets Rs m2,4800 6,199,500.0%   
Share capital Rs m123313 39.4%   
"Free" reserves Rs m7,018-4 -178,121.8%   
Net worth Rs m7,141309 2,311.7%   
Long term debt Rs m03 0.0%   
Total assets Rs m11,703320 3,656.6%  
Interest coverage x6.2NM-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.30 1,004.7%   
Return on assets %2.40.1 3,273.0%  
Return on equity %2.90.1 3,805.2%  
Return on capital %6.70.1 6,544.8%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-6923 -25,633.3%  
From Investments Rs m952-4 -24,781.3%  
From Financial Activity Rs m-368NA-  
Net Cashflow Rs m-109-1 9,517.5%  

Share Holding

Indian Promoters % 0.0 3.3 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 96.7 30.3%  
Shareholders   45,141 4,554 991.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   AAREY DRUGS  A-1 ACID  SALORA INTNL  CHEMTECH INDUST.  HKG  



Today's Market

Sensex Ends 145 Points Higher, Nifty Holds 18,100; ICICI Bank Rallies 12%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally higher.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Oct 25, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - BANGALORE FORT FARMS COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS